Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 20 citing articles:

Inclisiran: a new generation of lipid-lowering siRNA therapeutic
Yanzhen Zhang, Huaigang Chen, Lang Hong, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 24
Review of Associations of Diabetes and Insulin Resistance With Brain Health in Three Harmonised Cohort Studies of Ageing and Dementia
Roshni Biswas, Ana W. Capuano, Rupal I. Mehta, et al.
Diabetes/Metabolism Research and Reviews (2025) Vol. 41, Iss. 1
Open Access | Times Cited: 1
Association of PCSK9 with inflammation and platelet activation markers and recurrent cardiovascular risks in STEMI patients undergoing primary PCI with or without diabetes
Li Song, Xiaoxiao Zhao, Runzhen Chen, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 26
Sex difference in circulating PCSK9 and its clinical implications
Fang Jia, Si-Fan Fei, Debing Tong, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 22
U‐shaped association between serum IGF2BP3 and T2DM: A cross‐sectional study in Chinese population
Xiaoying Wu, Wei Wang, Shujin Fan, et al.
Journal of Diabetes (2023) Vol. 15, Iss. 4, pp. 349-361
Open Access | Times Cited: 11
Proprotein convertase subtilisin/kexin type 9: a promising marker of cardiovascular risk in post-menopausal diabetic women in primary prevention
Michelangelo Rottura, María Antonietta Barbieri, Carmine Siniscalchi, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Correlation of glycosylated apolipoprotein A1 and glycosylated low-density lipoprotein cholesterol levels with glucose homeostasis and the risk of developing type 2 diabetes mellitus
Jun-Xu Gu, Tingting Hong, Aimin Zhang, et al.
Diabetes Research and Clinical Practice (2025), pp. 112155-112155
Open Access
The Impact of PCSK9 on Risk Factors for Ischemic Stroke and Potential Mechanisms
Zehua He, Mingtian Lu, Zhejing Ding, et al.
American Journal of Molecular Biology (2025) Vol. 15, Iss. 01, pp. 110-122
Open Access
The correlation between proprotein convertase subtilisin/kexin type 9 and adiponectin in the progression from prediabetes to type 2 diabetes mellitus
Jun-Xu Gu, Kun Wang, Aimin Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Proprotein convertase subtilisin/kexin type 9 (PCSK9) and clinical outcomes in dialysis patients
Claudia Torino, Federico Carbone, Patrizia Pizzini, et al.
European Journal of Clinical Investigation (2024) Vol. 54, Iss. 9
Closed Access | Times Cited: 2
Correlation Between Circulating PCSK9 Levels and Gestational Diabetes Mellitus in a Chinese Population
Yiming Wu, Jie Shi, Qing Su, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 10
Real-world data on metabolic effects of PCSK9 inhibitors in a tertiary care center in patients with and without diabetes mellitus
Laurenz T. Fischer, Daniel A. Hochfellner, Lisa Knoll, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 14
Effect of Triglyceride-Glucose Indices and Circulating PCSK9-Associated Cardiovascular Risk in STEMI Patients with Primary Percutaneous Coronary Artery Disease: A Prospective Cohort Study
Xiaoxiao Zhao, Li Song, Jiannan Li, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 269-282
Open Access | Times Cited: 5
Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from the CORDIOPREV study
Elena M. Yubero‐Serrano, Juan F. Alcalá‐Díaz, Francisco M. Gutierrez‐Mariscal, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 12
The Impact of PCSK9 Gene Polymorphisms on Ischemic Stroke: A Systematic Review and Meta-Analysis
Jianhong Wang, Shuang Li, Yi Ren, et al.
Journal of Integrative Neuroscience (2024) Vol. 23, Iss. 3
Open Access | Times Cited: 1
Serum proprotein convertase subtilisin/Kexin type 9 and vascular disease in type 2 diabetic patients
Giuseppe Armentaro, Federico Carbone, Velia Cassano, et al.
European Journal of Clinical Investigation (2022) Vol. 53, Iss. 3
Open Access | Times Cited: 4
The predictive utility of circulating PCSK9 levels on diabetes mellitus
Jia Peng, Cheng‐Gang Zhu, Jian‐Jun Li
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 5
Unusual effects of PCSK9 E670G (rs505151) variation in patients with in-stent restenosis: Variable effects on restenosis risk according to concomitant chronic conditions
Gülçin Özkara, Ezgi Irmak Aslan, Ayşe Begüm Ceviz, et al.
Nucleosides Nucleotides & Nucleic Acids (2024), pp. 1-21
Open Access
Role of extracellular vesicles in insulin resistance: Signaling pathways, bioactive substances, miRNAs, and therapeutic potential
Wang Zhang, Mengdi Song, Zhou Fang, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 3
Closed Access
Association of genetic polymorphisms of PCSK9 with type 2 diabetes in Uygur Chinese population
Mengmeng Wang, Chen-Fei Lu, Shi-qi Yan, et al.
BMC Cardiovascular Disorders (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Page 1

Scroll to top